NATURE’S SUNSHINE PRODUCTS, INC. Accumulated Other Comprehensive Income
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Accumulated Other Comprehensive Income of -$17.05 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$17.05M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$17.38M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$17.57M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$15.87M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$17.05M 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$17.38M 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$17.57M 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$15.87M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$14.47M 10-Q · filed 2025-07-31 |
| 2025-03-31 | -$16.02M 10-Q · filed 2025-05-06 |
| 2024-12-31 | -$16.67M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$15.15M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$16.79M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$17.04M 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$15.35M 10-K · filed 2025-03-11 |
| 2023-09-30 | -$16.80M 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$16.21M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$14.97M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$13.31M 10-K · filed 2024-03-12 |
| 2022-09-30 | -$16.18M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$13.64M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$11.18M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$10.21M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$11.05M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$10.12M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$10.08M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$9.96M 10-K · filed 2022-03-08 |
| 2020-09-30 | -$10.77M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$11.48M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$11.33M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$11.22M 10-K · filed 2021-03-10 |
| 2019-09-30 | -$12.01M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$11.95M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$11.42M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$11.11M 10-K · filed 2020-03-11 |
| 2018-09-30 | -$10.39M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$10.40M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$10.35M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$10.13M 10-K · filed 2019-03-08 |
| 2017-09-30 | -$10.77M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$10.88M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$10.35M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$11.26M 10-K · filed 2018-03-16 |
| 2016-09-30 | -$9.94M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$10.77M 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$11.31M 10-Q · filed 2016-05-10 |
| 2015-12-31 | -$11.24M 10-K · filed 2017-03-14 |
| 2015-09-30 | -$10.98M 10-Q · filed 2015-11-06 |
| 2015-06-30 | -$11.62M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$11.20M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$11.20M 10-K · filed 2016-03-14 |
| 2014-09-30 | -$14.11M 10-Q · filed 2014-11-06 |
| 2014-06-30 | -$12.98M 10-Q · filed 2014-08-07 |
| 2014-03-31 | -$13.78M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$13.96M 10-K · filed 2016-03-14 |
| 2013-09-30 | -$13.30M 10-Q · filed 2013-11-08 |
| 2013-06-30 | -$14.46M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$12.43M 10-Q · filed 2013-05-09 |
| 2012-12-31 | -$10.57M 10-K · filed 2016-03-14 |
| 2012-09-30 | -$8.97M 10-Q · filed 2012-11-06 |
| 2012-06-30 | -$10.40M 10-Q · filed 2012-08-03 |
| 2012-03-31 | -$9.92M 10-Q · filed 2012-05-08 |
| 2011-12-31 | -$10.07M 10-K · filed 2015-03-13 |
| 2011-09-30 | -$7.92M 10-Q · filed 2011-11-08 |
| 2011-06-30 | -$6.14M 10-Q · filed 2011-08-05 |
| 2010-12-31 | -$7.65M 10-K · filed 2014-03-17 |
| 2009-12-31 | -$19.60M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |